← Back to patent-cliff list
CAS 820217-06-9
Bromo(2,4,6-tricyclohexylphenyl)magnesium
Codes: (XI)270899-2-b
Application context (from source-drug indications)
Major depressive disorderEsketamine HydrochlorideSuicidal ideationEsketamine HydrochlorideDepressive disorderEsketamine HydrochlorideAnaesthesiaEsketamine HydrochlorideTreatment-resistant depressionEsketamine HydrochloridePainEsketamine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Esketamine Hydrochloride | Tier B — Position early | 2029 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(aR)-3,3'-Diiodo-2,2'-bis(methoxymethoxy)-6,6'-dioctyl-1,1'-binaphthalene→Bromo(2,4,6-tricyclohexylphenyl)magnesium→(aR)-6,6'-Dioctyl-3,3'-bis(2,4,6-tricyclohexylphenyl)-1,1'-binaphthalene-2,2'-diol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.